Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Akero Therapeutics
Akero Therapeutics
89Bio Enlivened by Nash success
89Bio Enlivened by Nash success
EP Vantage
89Bio
NASH
Akero Therapeutics
pegozafermin
INTERCEPT
Madrigal Pharmaceuticals
Flag link:
89bio’s PhII data add to quick succession of NASH readouts as field seeks turnaround
89bio’s PhII data add to quick succession of NASH readouts as field seeks turnaround
Endpoints
89Bio
NASH
clinical trials
gozafermin
Akero Therapeutics
Flag link:
Pfizer Makes Supportive Investment in Akero's NASH Drug
Pfizer Makes Supportive Investment in Akero's NASH Drug
BioSpace
Akero Therapeutics
Pfizer
NASH
Flag link:
Analysts hail Akero's midphase NASH data as best in class
Analysts hail Akero's midphase NASH data as best in class
Fierce Biotech
Akero Therapeutics
clinical trials
NASH
efruxifermin
Flag link:
Akero’s success gives a new Nash mechanism hope
Akero’s success gives a new Nash mechanism hope
EP Vantage
Akero Therapeutics
NASH
AKR-001
Flag link:
Upcoming events – Bayer and Merck look to vericiguat, and Akero bets on Nash
Upcoming events – Bayer and Merck look to vericiguat, and Akero bets on Nash
EP Vantage
Bayer
Merck
vericiguat
heart failure
AKR-001
Akero Therapeutics
clinical trials
NASH
Flag link:
Back to business for biotech flotations
Back to business for biotech flotations
EP Vantage
IPOs
BridgeBio
Turning Point Therapeutics
Stoke Therapeutics
Prevail Therapeutics
Atreca
NGM Biopharmaceuticals
Akero Therapeutics
Milestone Pharmaceuticals
Morphic Therapeutics
Karuna
Flag link:
Four More Through the IPO Door as Life Science Firms Raise $465M
Four More Through the IPO Door as Life Science Firms Raise $465M
Xconomy
IPOs
Personalis
Akero Therapeutics
Prevail Therapeutics
Atreca
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
FDA
Merck
Arqule
Affimed
BeiGene
Epizyme
MorphoSys
Theravance
Allena Pharma
Akero Therapeutics
Atreca
Dermavant Sciences
Personalis
Prevail Therapeutics
Stoke Therapeutics
IPOs
Flag link:
New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero
New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero
BioCentury
IPOs
BridgeBio
Dermavant
Prevail Therapeutics
Atreca
Akero Therapeutics
Flag link:
Upstart Akero continues its swoosh into NASH space with $70M windfall round
Upstart Akero continues its swoosh into NASH space with $70M windfall round
Endpoints
Akero Therapeutics
NASH
AKR-001
Flag link: